Nucleic acid vaccines against hepatitis viruses

Area of Science:

• Immunology
• Vaccinology
• Molecular Biology

Background:

• Direct DNA injection stimulates potent antiviral immunity.
• Hepatitis B virus (HBV) S gene DNA vaccines induce anti-HBs and CD8+ CTL responses.
• No vaccine currently exists for Hepatitis C virus (HCV).

Purpose of the Study:

• To develop a DNA vaccine strategy for HCV.
• To evaluate the immunogenicity of plasmid DNA encoding HCV structural genes (C, E1, E2).
• To identify conserved antigenic epitopes within the HCV E2 protein.

Main Methods:

• Cloning of HCV genotype 1a structural genes (C, E1, E2) into pcDNA3 plasmid.
• Direct intramuscular injection of plasmid DNA into BALB/c mice.
• Analysis of mouse antisera reactivity against conserved sequences using overlapping peptides.

Main Results:

• Intramuscular DNA injection led to intracellular expression of HCV E1 and E2 proteins.
• Two conserved, overlapping epitopes in the E2 protein were identified (residues 581-591 and 590-603).
• These epitopes are recognized by human antibodies and show homology to flavivirus proteins.

Conclusions:

• DNA vaccination is an efficient method for presenting viral antigens.
• The identified E2 epitopes are promising targets for HCV vaccine development.
• This approach holds potential for high seroconversion rates and virus clearance in chronic liver disease.